Coronavirus Vaccine by CanSino is 75% Effective in Pakistan: Faisal Sultan
According to SAPM on Health, Dr. Faisal Sultan, in the Pakistani subset, the Cansino vaccine offered 75% protection against symptomatic cases and 100% protection against severe infection.
Dr. Faisal added that no serious safety concerns and side-effects of the Cansino vaccine were reported during the multination clinical trial.
Clinical trial data (phase-3) of a one-dose Ad5-nCoV vaccine for Covid (Cansino Bio) received. Interim analysis by the Independent Data Monitoring Committee shows 65.7% efficacy at preventing symptomatic cases and 90.98% at preventing severe disease (multicountry analysis).
— Faisal Sultan (@fslsltn) February 8, 2021
Pakistan has already booked enough CanSino’s COVID-19 vaccine doses to vaccinate 20 million citizens.
CanSino’s vaccine is the third Chinese vaccine to hit the markets. Sinovac and Sinopharm have developed the other two and both have been approved for use in numerous countries.
Pakistan has received 0.5 million doses of Sinopharm’s Coronavirus vaccine while another 0.5 million doses of the vaccine will reach the country soon. 1 million doses of Sinopharm will help the government vaccinate 0.5 million citizens.
Help Us Improve This Article
Did you find an inaccuracy? We work hard to provide accurate and scientifically reliable information. If you have found an error of any kind, please let us know.
Add comment. we appropriate your effort.
If you have any news, helping material, etc, kindly share it with us at firstname.lastname@example.org. We help others on behalf of you